• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症患者血清和脑脊液的免疫学检查结果

Serum and CSF immunological findings in ALS.

作者信息

Apostolski S, Nikolić J, Bugarski-Prokopljević C, Miletić V, Pavlović S, Filipović S

机构信息

Department of Neurology, University Clinical Centre, Belgrade, Yugoslavia.

出版信息

Acta Neurol Scand. 1991 Feb;83(2):96-8. doi: 10.1111/j.1600-0404.1991.tb04656.x.

DOI:10.1111/j.1600-0404.1991.tb04656.x
PMID:2017904
Abstract

Serum and CSF immunological findings were analysed in 37 patients with amyotrophic lateral sclerosis (ALS). ALS patients had significantly higher mean values of serum IgG and complement component C4 and significantly lower mean value of total haemolytic titre of complement (THC) compared with normal controls. Incidence of immune complexes (ICs) was significantly higher in sera of ALS patients than in normal controls. There was no significant difference regarding mean serum levels of IgM, IgA, and complement components C3 and Factor B between patients and controls. The blood-brain barrier (BBB) damage was found in 46% of patients. Intrathecal IgG synthesis was detected in six patients (16%). These results support the hypothesis of immune system involvement in ALS.

摘要

对37例肌萎缩侧索硬化症(ALS)患者的血清和脑脊液免疫学结果进行了分析。与正常对照组相比,ALS患者血清IgG和补体成分C4的平均值显著更高,而补体总溶血活性(THC)的平均值显著更低。ALS患者血清中免疫复合物(ICs)的发生率显著高于正常对照组。患者与对照组之间IgM、IgA以及补体成分C3和B因子的血清平均水平无显著差异。46%的患者存在血脑屏障(BBB)损伤。6例患者(16%)检测到鞘内IgG合成。这些结果支持免疫系统参与ALS的假说。

相似文献

1
Serum and CSF immunological findings in ALS.肌萎缩侧索硬化症患者血清和脑脊液的免疫学检查结果
Acta Neurol Scand. 1991 Feb;83(2):96-8. doi: 10.1111/j.1600-0404.1991.tb04656.x.
2
High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.肌萎缩侧索硬化症患者脑脊液中C3c水平升高。
Acta Neurol Scand. 1985 Jul;72(1):61-4. doi: 10.1111/j.1600-0404.1985.tb01548.x.
3
Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中C4d补体蛋白浓度升高。
J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):859-61. doi: 10.1136/jnnp.57.7.859.
4
Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel.吡喹酮治疗脑实质型囊尾蚴病患者的体液免疫反应
J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):254-7. doi: 10.1136/jnnp.52.2.254.
5
Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.肌萎缩侧索硬化症患者的免疫特征及其对病毒和中枢神经系统抗原的细胞介导免疫反应。
Clin Exp Immunol. 1982 Apr;48(1):137-46.
6
Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的脑脊液检查结果
J Neurol. 1984;231(2):75-8. doi: 10.1007/BF00313720.
7
Diffuse CNS involvement in systemic lupus erythematosus: intrathecal synthesis of the 4th component of complement.系统性红斑狼疮中枢神经系统的弥漫性受累:补体第四成分的鞘内合成。
Neurology. 1990 Oct;40(10):1593-6. doi: 10.1212/wnl.40.10.1593.
8
Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.中枢神经系统免疫性疾病中的脑脊液C3和C4指标
Acta Neurol Scand. 2000 Feb;101(2):116-21. doi: 10.1034/j.1600-0404.2000.101002116.x.
9
[Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
Nervenarzt. 1991 Feb;62(2):127-9.
10
Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.神经系统疾病中的脑脊液免疫球蛋白商、κ/λ比值及病毒抗体滴度
J Clin Pathol. 1976 Dec;29(12):1105-15. doi: 10.1136/jcp.29.12.1105.

引用本文的文献

1
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.齐卢可泮治疗肌萎缩侧索硬化症的疗效与安全性:一项随机临床试验
JAMA Netw Open. 2025 Feb 3;8(2):e2459058. doi: 10.1001/jamanetworkopen.2024.59058.
2
Blood-Spinal Cord Barrier: Its Role in Spinal Disorders and Emerging Therapeutic Strategies.血脊髓屏障:其在脊髓疾病中的作用及新兴治疗策略
NeuroSci. 2021 Dec 21;3(1):1-27. doi: 10.3390/neurosci3010001. eCollection 2022 Mar.
3
Immunology of amyotrophic lateral sclerosis - role of the innate and adaptive immunity.
肌萎缩侧索硬化症的免疫学——先天免疫和适应性免疫的作用
Front Neurosci. 2023 Nov 30;17:1277399. doi: 10.3389/fnins.2023.1277399. eCollection 2023.
4
Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.星形胶质细胞:在肌萎缩侧索硬化症和额颞叶痴呆中的作用解析。
Cells. 2023 May 23;12(11):1450. doi: 10.3390/cells12111450.
5
CSF oligoclonal IgG bands are not associated with ALS progression and prognosis.脑脊液寡克隆IgG带与肌萎缩侧索硬化症的进展和预后无关。
Front Neurol. 2023 May 5;14:1170360. doi: 10.3389/fneur.2023.1170360. eCollection 2023.
6
Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case-control studies.人体组织铅(Pb)水平与肌萎缩侧索硬化症:病例对照研究的系统评价和荟萃分析。
Neurol Sci. 2022 Oct;43(10):5851-5859. doi: 10.1007/s10072-022-06237-y. Epub 2022 Jul 9.
7
Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的神经炎症和血脑屏障渗漏的血清生物标志物。
BMC Neurol. 2022 Jun 11;22(1):216. doi: 10.1186/s12883-022-02730-1.
8
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain.肌萎缩侧索硬化生物流体生物标志物的多中心评估显示血液神经丝轻链最为重要。
Brain Commun. 2022 Feb 9;4(1):fcac029. doi: 10.1093/braincomms/fcac029. eCollection 2022.
9
Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.辅助性谱系阴性细胞疗法作为肌萎缩侧索硬化症患者补体介导免疫系统的潜在抑制因素
J Clin Med. 2021 Nov 11;10(22):5251. doi: 10.3390/jcm10225251.
10
Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia.血脑屏障功能障碍与髓鞘碱性蛋白在伴或不伴额颞叶痴呆的肌萎缩侧索硬化症存活中的作用
Neurol Sci. 2022 May;43(5):3201-3210. doi: 10.1007/s10072-021-05731-z. Epub 2021 Nov 26.